1XJ: 4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-[(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl)sulfonyl]benzamide
1XJ is a Ligand Of Interest in 4QNQ designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4QNQ_1XJ_B_301 | 81% | 9% | 0.126 | 0.978 | 1.49 | 2.88 | 12 | 32 | 2 | 0 | 100% | 1 |
4QNQ_1XJ_D_301 | 79% | 10% | 0.132 | 0.979 | 1.81 | 2.5 | 12 | 25 | 2 | 0 | 100% | 1 |
4QNQ_1XJ_G_301 | 78% | 7% | 0.129 | 0.973 | 1.54 | 3.29 | 10 | 35 | 2 | 0 | 100% | 1 |
4QNQ_1XJ_K_301 | 78% | 8% | 0.128 | 0.97 | 1.41 | 3.18 | 12 | 38 | 3 | 0 | 100% | 1 |
4QNQ_1XJ_E_301 | 74% | 8% | 0.139 | 0.971 | 1.46 | 3.19 | 9 | 31 | 2 | 0 | 100% | 1 |
4QNQ_1XJ_H_301 | 74% | 7% | 0.141 | 0.973 | 1.57 | 3.23 | 14 | 30 | 1 | 0 | 100% | 1 |
4QNQ_1XJ_A_301 | 73% | 7% | 0.144 | 0.972 | 2.05 | 2.82 | 17 | 35 | 2 | 0 | 100% | 1 |
4QNQ_1XJ_F_301 | 73% | 6% | 0.137 | 0.963 | 1.71 | 3.38 | 14 | 40 | 2 | 0 | 100% | 1 |
4QNQ_1XJ_L_301 | 69% | 8% | 0.146 | 0.961 | 1.52 | 3.09 | 12 | 38 | 3 | 0 | 100% | 1 |
4QNQ_1XJ_C_301 | 69% | 7% | 0.15 | 0.965 | 1.57 | 3.26 | 11 | 33 | 0 | 0 | 100% | 1 |
4QNQ_1XJ_J_301 | 68% | 7% | 0.149 | 0.961 | 1.61 | 3.23 | 12 | 30 | 5 | 0 | 100% | 1 |
4QNQ_1XJ_I_301 | 66% | 6% | 0.154 | 0.96 | 1.68 | 3.23 | 14 | 34 | 1 | 0 | 100% | 1 |
4LVT_1XJ_A_301 | 87% | 35% | 0.096 | 0.968 | 1.01 | 1.55 | 4 | 18 | 0 | 0 | 100% | 1 |
6QGH_1XJ_A_401 | 85% | 17% | 0.103 | 0.969 | 2.34 | 1.31 | 12 | 8 | 1 | 0 | 100% | 1 |